2XAD image
Deposition Date 2010-03-31
Release Date 2011-03-02
Last Version Date 2025-04-09
Entry Detail
PDB ID:
2XAD
Title:
Crystal structure of deacetylase-teicoplanin complex in biosynthesis pathway of teicoplanin
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE
Gene (Uniprot):tcp14
Mutagens:YES
Chain IDs:A, B, C, D
Chain Length:273
Number of Molecules:4
Biological Source:ACTINOPLANES TEICHOMYCETICUS
Polymer Type:polypeptide(L)
Molecule:TEICOPLANIN
Chain IDs:E, F, G, H
Chain Length:7
Number of Molecules:4
Biological Source:NONOMURAEA SP. ATCC 39727
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
3MY E TYR 3-CHLORO-D-TYROSINE
MSE A MET SELENOMETHIONINE
OMY E TYR ?
Peptide-like Molecules
PRD_000209
Primary Citation
Regioselective Deacetylation Based on Teicoplanin-Complexed Orf2 Crystal Structures.
Mol.Biosyst. 7 1224 ? (2011)
PMID: 21267472 DOI: 10.1039/C0MB00320D

Abstact

Lipoglycopeptide antibiotics are more effective than vancomycin against MRSA as they carry an extra aliphatic acyl side chain on glucosamine (Glm) at residue 4 (r4). The biosynthesis of the r4 N-acyl Glc moiety at teicoplanin (Tei) or A40926 has been elucidated, in which the primary amine nucleophile of Glm is freed from the r4 GlcNac pseudo-Tei precursor by Orf2* for the subsequent acylation reaction to occur. In this report, two Orf2* structures in complex with β-D-octyl glucoside or Tei were solved. Of the complexed structures, the substrate binding site and a previously unknown hydrophobic cavity were revealed, wherein r4 GlcNac acts as the key signature for molecular recognition and the cavity allows substrates carrying longer acyl side chains in addition to the acetyl group. On the basis of the complexed structures, a triple-mutation mutant S98A/V121A/F193Y is able to regioselectively deacetylate r6 GlcNac pseudo-Tei instead of that at r4. Thereby, novel analogs can be made at the r6 sugar moiety.

Legend

Protein

Chemical

Disease

Primary Citation of related structures